United States · FDA National Drug Code directory

Bosutinib

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
62332-311_45618427-a81b-436a-9326-8de755cb1eb9
Product NDC
62332-311
Form
TABLET, FILM COATED
Composition / generic term
Bosutinib
Labeler
Alembic Pharmaceuticals Inc.
Marketing category
ANDA
Marketing start / end (source format)
20260519
Source listing expiry
20271231

Source-listed ingredients

  • BOSUTINIB — 100 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 120 TABLET, FILM COATED in 1 BOTTLE (62332-311-35) · 62332-311-35

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →